News | July 21, 2023
Tillotts Pharma and TVM Capital form Mage Biologics to develop oral antibody therapy for ulcerative colitis
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
CMOs showed an increasing reluctance to take on debt in 2022
Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Moist wound dressing for chronic wound treatment now available in Germany
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
Subscribe To Our Newsletter & Stay Updated
